Neonatal Encephalopathy Clinical Trial
Official title:
Diagnostic Value of the Neonatal Neurological Examination to Detect Infants at Risk for Neurological Abnormalities
NCT number | NCT05772416 |
Other study ID # | 4313 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | September 1, 2021 |
Est. completion date | August 31, 2025 |
The study aims to establish the diagnostic vcalue of a structured neurological examination to detect eraly neurological abnormlaities in infants at risk of neurological abnormlaiyies.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | August 31, 2025 |
Est. primary completion date | August 31, 2025 |
Accepts healthy volunteers | |
Gender | All |
Age group | 6 Hours to 1 Week |
Eligibility | Inclusion Criteria: all newborns with neonatal encephaolopathy or at risk for neurological abnormlaities, such as preterm infants born below 34 weeks or those with convusions Exclusion Criteria: families unwilling to sign consent |
Country | Name | City | State |
---|---|---|---|
Italy | Policlinico gemelli | Rome |
Lead Sponsor | Collaborator |
---|---|
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hammersmith Neonatal and infant Neurological examination | neurological examination witha score from 0 to 75 with 75 indicating best performance | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05471336 -
Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)
|
N/A | |
Recruiting |
NCT05514340 -
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
|
Phase 2 | |
Recruiting |
NCT04603547 -
Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy
|
||
Completed |
NCT01913340 -
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
|
Phase 1/Phase 2 | |
Completed |
NCT00581581 -
CoolCap Followup Study-Coordination of Participating Centers
|
N/A | |
Completed |
NCT03122808 -
Uterine Activity in Moderate-Severe Neonatal Encephalopathy: A Case Control Study
|
||
Recruiting |
NCT02544100 -
Neonatal Neurologic Intensive Care Network of China
|
||
Completed |
NCT03380013 -
OMT to Improve Feeding After Hypothermia
|
N/A | |
Active, not recruiting |
NCT03409770 -
Optimising the Duration of Cooling in Mild Encephalopathy
|
N/A | |
Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
Not yet recruiting |
NCT06098833 -
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia
|
Phase 2 | |
Not yet recruiting |
NCT05756296 -
The Long-term Consequences of Neonatal Encephalopathy in the Hypothermia Era
|
||
Recruiting |
NCT04432662 -
Darbepoetin in Neonatal Encephalopathy Trial
|
Phase 2 | |
Recruiting |
NCT02793999 -
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
|
||
Not yet recruiting |
NCT05889507 -
Cooling in Mild Encephalopathy
|
N/A | |
Recruiting |
NCT05848271 -
Natural History Study of Patients With HPDL Mutations
|
||
Not yet recruiting |
NCT04176471 -
TIME Study: Therapeutic Hypothermia for Infants With Mild Encephalopathy
|
N/A | |
Completed |
NCT01309711 -
Magnetic Resonance Biomarkers in Neonatal Encephalopathy
|
||
Recruiting |
NCT04225975 -
Neonate Cerebral Activity in Immediate Post Partum
|
N/A | |
Recruiting |
NCT05610085 -
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
|
Phase 2 |